PKI - PerkinElmer, Inc.

NYSE - NYSE Delayed Price. Currency in USD
93.91
-0.60 (-0.63%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close94.51
Open94.70
Bid94.16 x 800
Ask94.20 x 1100
Day's Range93.88 - 95.29
52 Week Range71.31 - 103.00
Volume325,048
Avg. Volume882,245
Market Cap10.416B
Beta (3Y Monthly)1.47
PE Ratio (TTM)42.23
EPS (TTM)2.22
Earnings DateJul 30, 2019 - Aug 5, 2019
Forward Dividend & Yield0.28 (0.30%)
Ex-Dividend Date2019-07-18
1y Target Est101.38
Trade prices are not sourced from all markets
  • Here's Why You Should Hold PerkinElmer (PKI) Stock for Now
    Zacks7 days ago

    Here's Why You Should Hold PerkinElmer (PKI) Stock for Now

    PerkinElmer (PKI) raises earnings per share guidance for 2019.

  • Here’s What Hedge Funds Think About PerkinElmer, Inc. (PKI)
    Insider Monkey7 days ago

    Here’s What Hedge Funds Think About PerkinElmer, Inc. (PKI)

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]

  • Markit9 days ago

    See what the IHS Markit Score report has to say about PerkinElmer Inc.

    PerkinElmer Inc NYSE:PKIView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low and declining Bearish sentimentShort interest | PositiveShort interest is low for PKI with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 14. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold PKI had net inflows of $5.89 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. PKI credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Did You Miss PerkinElmer's (NYSE:PKI) 82% Share Price Gain?
    Simply Wall St.28 days ago

    Did You Miss PerkinElmer's (NYSE:PKI) 82% Share Price Gain?

    It hasn't been the best quarter for PerkinElmer, Inc. (NYSE:PKI) shareholders, since the share price has fallen 12% in...

  • Business Wire29 days ago

    PerkinElmer to Present at Goldman Sachs Global Healthcare Conference

    PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Goldman Sachs 40th Annual Global Healthcare Conference on Wednesday, June 12, 2019, at 2:40 p.m. PT in Rancho Palos Verdes, California. Prahlad Singh, PerkinElmer’s president and chief operating officer, will provide an overview of the Company and its strategic priorities.

  • PerkinElmer (PKI) Down 9.2% Since Last Earnings Report: Can It Rebound?
    Zackslast month

    PerkinElmer (PKI) Down 9.2% Since Last Earnings Report: Can It Rebound?

    PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now
    Zackslast month

    Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

    PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

  • Should You Be Tempted To Sell PerkinElmer, Inc. (NYSE:PKI) Because Of Its P/E Ratio?
    Simply Wall St.2 months ago

    Should You Be Tempted To Sell PerkinElmer, Inc. (NYSE:PKI) Because Of Its P/E Ratio?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To ke...

  • The 10 Best Stocks to Buy for May
    InvestorPlace2 months ago

    The 10 Best Stocks to Buy for May

    The end of April and the beginning of May isn't just a transition from one month to the next. For investors, the turn of the calendar between these two particular months marks an end to the best six months of the year for stocks and a move to the weakest six months of the year. The whole "sell in May" thing is rooted in reality.Just because the broad tailwind has stopped blowing, however, doesn't necessarily mean every stock is ready to stagnate here. It just means investors should be more selective than they might normally be. * 7 Stocks That Are Soaring This Earnings Season With that as the backdrop, here's a rundown of some of the top stocks to buy -- rather than sell -- as the month of May gets going. These picks have demonstrated some sort of edge headed into this slow time of year. Either there's budding technical bullishness in play, or extreme value, or in many cases, both. In no particular order…InvestorPlace - Stock Market News, Stock Advice & Trading Tips Molson Coors Brewing (TAP)Beer giant Molson Coors Brewing (NYSE:TAP), the company behind brands like Bergenbier, Blue Moon and of course Molson, had a rough go of things between late-2016 and late 2018. All told, TAP stock fell more than 50% from peak to trough in response to a sales slowdown that ended up crimping earnings.Challenges remain. So do doubts. Two years of misery will force a company to regroup, though, and without saying as much, enough bulls have plowed in at recent long-term lows to snap Molson Coors shares out a well-framed downtrend and back above the 200-day moving average line for the first time since early 2017.The kicker: Revenue is expected to stabilize next year, reversing the earnings decline. That is, this year's projected profit of $4.76 per share is forecasted to grow to $4.92 per share next year. That appears to be just enough to spur some new bullishness. DowDuPont (DWDP)DowDuPont (NYSE:DWDP) has been through several structural shakeups over the course of the past few years, with the most recent being the spinoff of Dow (NYSE:DOW) a month ago. Come June 1, the company's agricultural arm Corteva will also be separated from its parent.The breakup has been inspired by the same reason for all corporate splits -- as a means of unlocking value and letting each unit operate without being distracted by other unlike business arms.In this instance, however, there's a nuance that's making DWDP one of the top stocks to by before or after the impending separation of Corteva. That is, traders are already starting to file back into the stock after a rough 2018, suggesting they already realize the upside of the breakup. * 7 Stocks to Buy That Ought to Buy Back Shares Take the hint at face value, particularly if DWDP shares can push above the technical ceiling waiting at $40.43. Expedia Group (EXPE)Years ago, when the internet was still young, the tourism industry struggled to connect with consumers online. Online travel arrangement middlemen like Expedia Group (NASDAQ:EXPE) filled a gap quite nicely.That ceased to be the case a couple of year ago, however. Weary of sharing revenue with players like Expedia, airlines, hotels, car-rental agencies and everyone stepped up their online games and got serious about bypassing online travel agents. Expedia, along with Booking Holdings (NASDAQ:BKNG) and Trivago (NASDAQ:TRVG), were unable to demonstrate their actual value to the customers they were serving.That's starting to change, at least for Expedia, if the chart's recent action is any indication. After a rough 2017 and 2018, we're starting to see higher lows. Better yet, analysts anticipate revenue growth of 10% this year and next year, which should start to drive even more earnings growth now that the company has finally found its place again. Hewlett Packard Enterprise (HPE)Hewlett Packard Enterprise (NYSE:HPE) is, as you'll remember, the business side of the old Hewlett-Packard, which split from the consumer-oriented arm back in 2015.Though "Enterprise" got off to a good start, shares of HPE stock haven't made any net progress since August of 2016. It's not because the company hasn't been doing what it's supposed to do though. While sales growth has been anemic -- and will continue to be so through next year -- Hewlett Packard Enterprise has been able to leverage its leadership in the hybrid cloud arena into better margins. Last year's earnings of $1.56 per share are expected to grow to $1.65 this year, and reach $1.75 per share next year. * 7 A-Rated Stocks That Are Under $10 HPE's hybrid cloud tech is good enough to secure Google as a business partner, setting the stage for an unexpectedly strong 2019. PerkinElmer (PKI)Many investors may have never even heard of PerkinElmer (NYSE:PKI). But, don't mistake a lack of familiarity for a lack of size or strength. It's just a name that's doing a great deal of work behind the front lines of the healthcare world.PerkinElmer is a diagnostics outfit, helping caregivers diagnose and identify all sorts of medical problems. The company even offers environmental and food testing solutions. It's far from a sexy, headline-grabbing business, but it's reliable, and PKE is one of the best stocks to buy in this uncertain environment. Much like the company's top and bottom lines, PerkinElmer's stock's uptrend isn't thwarted for very long.The bullish case is bolstered by the recently reported first-quarter beat, which was followed by upped guidance. Even that may underestimate what's in store, however. For the past 12 quarters, PerkinElmer has only missed estimates twice, and has beat estimates nine of those times. ResMed (RMD)ResMed (NYSE:RMD) shares took one on the chin in January, losing 20% of its value after falling short of its fiscal Q2 revenue projection. The pros were calling for a top line of $673 million, but the company only reported $651 million.In retrospect, however, traders appear to realize they overshot their bearish target. RMD has reclaimed nearly half of what it lost in that one rough day, and the bulls continue to test the waters of higher highs.The pros are getting (back) on board too, with JP Morgan upgrading the stock last month, and Deutsche Bank upgrading it to a "buy" in March. JP Morgan's upgrade in April, in fact, reversed the knee-jerk downgrade the firm dished out on RMD immediately after that ill-fated earnings report. Looking back, JP Morgan's analysts still seem to appreciate this year's and next year's revenue is expected to grow by double-digits. * 7 Cloud Stocks to Buy Now The kicker: This is a bullish time of year for healthcare equipment names like ResMed. These stocks gain, on average, about 5% between early March and late July. Mohawk Industries (MHK)Mohawk Industries (NYSE:MHK) may not be a red-hot growth machine, but it doesn't have to be. Priced at only 11.5 times its forward-looking profit, Mohawk is a solid value prospect.Mohawk, of course, is the flooring company that's been around for ages. At one time only a carpet name, it has since diversified into tile, laminate and even countertops.Shares took a sizable tumble in 2018, falling from a high near $287 to a low around $109 in December of last year. The selloff reflected an admittedly disappointing year, marked by a sharp dropoff in revenue and earnings.The bears arguably hit it a little too hard, though, and this week's strong gains renew a rebound effort that got started in earnest in February. A break above the 200-day moving average line around $143 and the February high around $144.50 would seal the budding deal. Alexion Pharmaceuticals (ALXN)Alexion Pharmaceuticals (NASDAQ:ALXN) isn't exactly a mainstream name, but give it time -- that could change.Alexion's portfolio consists of four drugs, with a handful more in the pipeline. And, it's a perfect mix. Soliris is the breadwinner, driving $3.56 billion in sales last year, but a couple of its other, smaller drug saw sales growth of 40% in 2018. The mix of stability with strong growth translates into widening margins, and this year is shaping up to be a real profit breakout. Driven by almost 16% sales growth, analysts expect per-share earnings to swell from last year's $7.92 to $9.47. * 7 Dividend Stocks That Could Double Over the Next Five Years The stock has been stuck in a sideways range since 2017, but the budding effort to break back above $141 could be catalytic. Retail Properties of America (RPAI)The headlines suggest the so-called retail apocalypse is in full swing. The numbers suggest otherwise. Consumer spending grew 0.9% in March, which was the best single-month improvement in almost a decade. Calm inflation and rising wages are proving to be a real boon, and with the Federal Reserve in no particular hurry to raise interest rates, real estate remains cheap and easy to finance.Enter Retail Properties of America (NYSE:RPAI). This retail real estate investment trust (or REIT) was on its heels for the better part of 2017 and 2018, with investors concerned the company was on the wrong side of two different but related trends… interest rates and slowing retail consumption.Now, however, the bulls are quietly toying with a turnaround. A move above the technical ceilings at $13 and then $13.30 could prove game-changing. Hologic (HOLX)Finally, add Hologic (NASDAQ:HOLX) to your list of stocks to buy in May.Hologic is another diagnostics and testing name. Like most other organizations in the industry, red-hot growth isn't in the cards, but steady progress is. Only once since 2010 has the company failed to drive year-over-year quarterly sales growth.Though not without its ups and downs, the stock's long-term history reflects this consistency. * 7 Stocks That Are Soaring This Earnings Season The action seen over the course of just the past few days, though, makes HOLX a compelling prospect right now. After rushing higher early this year and developing an overbought condition by March, profit-takers dug in. It was where and how the rebound took shape that's telling. All it took was a kiss of the pivotal 200-day moving average line to rekindle the rally effort. The steep stumble simply hit the 'reset' button and cleared the decks for what could end up being a lengthy climb.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 7 A-Rated Stocks That Are Under $10 * 7 Stocks That Are Soaring This Earnings Season * 5 Biotech Stocks for a Long-Lived Portfolio * 10 Times Apple's Hardware Failed Consumers -- And Hurt Its Business Compare Brokers The post The 10 Best Stocks to Buy for May appeared first on InvestorPlace.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PKI earnings conference call or presentation 25-Apr-19 9:00pm GMT

    Q1 2019 PerkinElmer Inc Earnings Call

  • PerkinElmer (PKI) Beats on Q1 Earnings, Hikes '19 Guidance
    Zacks2 months ago

    PerkinElmer (PKI) Beats on Q1 Earnings, Hikes '19 Guidance

    PerkinElmer's (PKI) Q1 earnings gain from top-line growth, solid show by Diagnostics segment and strong margins. However, negative currency movement remains a headwind.

  • PERKINELMER INC (PKI) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    PERKINELMER INC (PKI) Q1 2019 Earnings Call Transcript

    PKI earnings call for the period ending March 31, 2019.

  • This Genetics Behemoth Just Outran First-Quarter Earnings Forecasts
    Investor's Business Daily2 months ago

    This Genetics Behemoth Just Outran First-Quarter Earnings Forecasts

    Illumina and PerkinElmer earnings beat first-quarter expectations when the two reported results late Thursday. But Illumina and PerkinElmer shares stumbled in action after the close.

  • Associated Press2 months ago

    PerkinElmer: 1Q Earnings Snapshot

    The Waltham, Massachusetts-based company said it had net income of 32 cents per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to 69 cents per share. ...

  • Business Wire2 months ago

    PerkinElmer Announces Financial Results for the First Quarter of 2019

    WALTHAM, Mass.-- -- Revenue of $648.7 million; 1% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.32; Adjusted EPS of $0.69 Acquisition of Cisbio Bioassays, a leading custom assay service provider, bolsters position in life sciences and diagnostics markets FY19 GAAP earnings per share guidance range of $2.85 to $2.90 from continuing operations; Raises Adjusted EPS guidance ...

  • Business Wire2 months ago

    PerkinElmer Board Declares Quarterly Dividend

    The Board of Directors of PerkinElmer, Inc. , declared a regular quarterly dividend of $0.07 per share of common stock on April 25, 2019. This dividend is payable on August 9, 2019 to all shareholders of record at the close of business on July 19, 2019.

  • Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?
    Zacks2 months ago

    Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?

    Strength in PerkinElmer's (PKI) core Diagnostics business is expected to drive Q1 results amid foreign exchange woes.

  • PerkinElmer (PKI) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks2 months ago

    PerkinElmer (PKI) Reports Next Week: Wall Street Expects Earnings Growth

    PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Varian Medical (VAR) to Report Q2 Earnings: What's in Store?
    Zacks2 months ago

    Varian Medical (VAR) to Report Q2 Earnings: What's in Store?

    Varian Medical (VAR) expects to gain significantly from APAC and EMEA regions in fiscal Q2.

  • What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?
    Zacks2 months ago

    What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?

    Edwards Lifesciences (EW) expects to gain from core Critical Care product group in Q1.

  • PerkinElmer eyes cannabis market for growth
    American City Business Journals2 months ago

    PerkinElmer eyes cannabis market for growth

    One of Massachusetts’ most established companies is moving into the marijuana business sector, with PerkinElmer announcing it has started selling testing equipment for cannabis labs.

  • 7 Mid-Cap Stocks to Find the Market’s Sweet Spot
    InvestorPlace2 months ago

    7 Mid-Cap Stocks to Find the Market’s Sweet Spot

    It looks like 2019 will shape up to be a "Goldilocks" economy -- not too hot, and not too cold, leaving stocks just right.After a blazing start to the year, everyone on the Street has been expecting earnings to tail off as 2019 ages. This isn't a surprise. The December 2017 tax cuts were a significant boost to corporate earnings in 2018. Whether companies used the extra money to pump up earnings by increasing stock buybacks or expanding their spending, it kept stocks humming up until Q4.That's when analysts started to realize that there wasn't going to be any more goodies in 2018's Christmas stocking and that consumers could only spend so much.InvestorPlace - Stock Market News, Stock Advice & Trading TipsPlus, all those good times kept the Federal Reserve on their anti-inflation mission, so things were looking bleak. But when the Fed reversed course and softened its stance, the market celebrated 2018's version of 2017's tax cut.But this year will ultimately favor stocks that are built to succeed in a mild-growth economy. These seven mid-cap stocks do best in the kind of slow-growth conditions we're in right now. * 7 Marijuana Companies: Which Pot Stocks Should You Buy? All these are A-rated momentum picks by their quantitative grade in my Portfolio Grader now, so they're all setting up for a strong year. Mid-Cap Stocks to Buy: ZTO Express (Cayman) Inc ADR (ZTO)Source: Shutterstock ZTO Express (Cayman) Inc ADR (NYSE:ZTO) is a China-based logistics firm that is listed in the U.S.The easiest way to understand what ZTO represents in China is to think about FedEx (NYSE:FDX) or UPS (NYSE:UPS) in the U.S. market. ZTO has that kind of reach in China. And one of its biggest customers is ecommerce giant Alibaba (NYSE:BABA). If you think Amazon (NASDAQ:AMZN) plays a big part among U.S. logistics companies, the Alibaba-ZTO combo is just as powerful.Recently, ZTO has been hurt by slow growth in China. But that is waning, and all signs are pointing to Chinese consumers and the economy getting back in step.Also, ZTO's recent earnings are very encouraging. This is a solid choice if you're looking to invest in the Chinese economy. PerkinElmer (PKI)Source: Shutterstock PerkinElmer (NYSE:PKI) is a life sciences company that dates back to 1937. Essentially, it builds laboratory equipment that can be used across a number of industries for product development, discovery and quality control. Its diversified client base and long reputation for quality products makes it a go-to company for life sciences technology.Domestically, one of the new sectors where its equipment is already seeing demand is in the exploding cannabis and CBD sector. Developing consistent, high-quality products as production scales up is crucial for market entrants that want to grow. * 7 AI Stocks to Watch with Strong Long-Term Narratives Outside the North America, PKI equipment is a popular choice in China as it ramps up healthcare spending and is focused on modernizing its homegrown industries. Lennox International (LII)Source: Aidan via Flickr (Modified)Lennox International (NYSE:LII) sells a very welcome product, especially in the Southern U.S.The joke in the South is, civilization became sustainable in the South when air conditioning was invented. So, it's no surprise that LII, which was founded in 1895, hangs its hat in Texas.Today, LII builds residential and commercial HVAC (heating, ventilation, air conditioning) systems and has a global distribution network in place. One of its big international opportunities is in India, where it has established a strong footprint, especially building out local HVAC technology teams.With the U.S. economy expanding and low interest rates available to businesses and individuals, new sales should be solid moving forward. Micro Focus International PLC (ADR) (MFGP)Source: Shutterstock Micro Focus International PLC (ADR) (NYSE:MFGP) is a UK-based tech company that has been around since 1976. It bought Hewlett Packard Enterprise's (NYSE:HPE) software business in late 2017 and has been struggling to digest it for a while. But those troubles seem over.Basically, MFGP creates bridge software that works with enterprise-level systems to boost the security, effectiveness and efficiencies of existing software platforms with emerging technologies.This is a huge issue with governments or large corporations that can't continually upgrade hardware for thousands of workers -- which means those organizations' ability to upgrade software is also hampered. * 10 Dow Jones Stocks Holding the Blue Chip Index Back These challenges become significant as technology advances and these systems are expected to do more with increasing levels of security. This niche is vital, and the fact that MFGP is working on both sides of the Atlantic is also a great competitive advantage. Jacobs Engineering Group (JEC)Source: Born1945 Via FlickJacobs Engineering Group (NYSE:JEC) is an engineering company based out of Dallas, Texas. But its reach is global, and it does all sorts of big projects, especially government buildings and infrastructure.Now, this certainly isn't the sexiest work out there, but the fact is it's solid, consistent work. That's what a lot of mid-caps are about. They have a niche they've developed for many years and they have scaled it up to build a very respectable book of business without leveraging the company or rolling the dice on some big idea.Slow and steady wins the race.One of its big global focuses is in India. Watching China grow from an agrarian society into the second-largest economy in the world in a matter of a few decades has been a competitive challenge for India to mirror that success. One of the keys to getting there is upgrading the infrastructure. JEC stock will certainly benefit. Steris (STE)Source: Shutterstock Steris (NYSE:STE) is a healthcare equipment and services company that is based in Ohio but over the years has expanded and acquired businesses around the globe.Currently, STE has 12,000 employees in more than 100 countries, particularly in the U.S. and Europe. But in recent years, it has been building out its operations in Asia, which should be a key growth driver in coming years.STE's specialty is procedures and equipment that help prevent infection or contamination of manufacturing equipment, patients or sterile environments. In the U.S., this kind of technology is crucial to lowering healthcare costs. In an Asian country like China, this niche is important in bringing its healthcare system up to modern standards for its 1.4 billion people. * 8 Risky Stocks to Watch as Earnings Season Kicks Off The point is, there's plenty of upside here, but it's likely to be slow and steady, not parabolic. Still, steady, long-term growth is a great thing for any portfolio. Pinnacle West Capital (PNW)Source: Robert via FlickrPinnacle West Capital (NYSE:PNW) essentially is a holding company for Arizona Public Service, which is a utility that provides electricity to more than 1 million Arizona residents and businesses.It has built a storied past, and the worst of its days are decades behind it at this point. And now it is also has a solid unregulated business to go along with its regulated one. Its Bright Canyon Energy subsidiary is focused on transmission infrastructure in Western states. This is going to be crucial as alternative energy resources come online and older equipment needs to be replaced or upgraded.Plus, PNW delivers a solid 3.1% dividend -- and that's after an impressive 22% run in the past 12 months.Louis Navellier is a renowned growth investor. He is the editor of four investing newsletters: Growth Investor, Breakthrough Stocks, Accelerated Profits and Platinum Growth. His most popular service, Growth Investor, has a track record of beating the market 3:1 over the last 14 years. He uses a combination of quantitative and fundamental analysis to identify market-beating stocks. Mr. Navellier has made his proven formula accessible to investors via his free, online stock rating tool, PortfolioGrader.com. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post 7 Mid-Cap Stocks to Find the Marketa€™s Sweet Spot appeared first on InvestorPlace.

  • Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?
    Zacks2 months ago

    Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?

    Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.